2023 Senate Joint Resolution 45
ENROLLED JOINT RESOLUTION
Relating to: designating Hypertrophic Cardiomyopathy Awareness Day and efforts to educate
people about hypertrophic cardiomyopathy.
Whereas, Hypertrophic Cardiomyopathy (HCM) is a chronic cardiovascular disease
involving thickening of the heart muscle and can potentially lead to debilitating symptoms and
serious complications including heart failure, atrial fibrillation, stroke, and in rare cases sudden
cardiac death; and
Whereas, HCM is the most common inheritable heart disease and can affect anyone regardless
of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general
population; and
Whereas, an estimated 700,000 to 1,650,000 people in the United States have HCM, yet 85
percent of them may remain undiagnosed; and
Whereas, HCM shares symptoms with other common cardiovascular and pulmonary diseases,
such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to
distinguish HCM from these other diseases; and
Whereas, all−cause mortality risk is three to four times higher in patients with HCM than that
of the general population; and
Whereas, knowing one’s medical history and any signs and symptoms of HCM is an important
first step in receiving an accurate diagnosis of HCM; and
Whereas, a healthcare provider must conduct a thorough screening with cardiac health
questions to help identify a risk of cardiac disorders both genetic and congenital; and
Whereas, a health−care provider may conduct several tests, including an echocardiogram, a
cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to
diagnose HCM; and
Whereas, following a diagnosis of HCM, it is important for patients to work with their
healthcare provider to learn more about their disease and understand different management options,
including prescription medicines and surgical treatment options that may help; and
Whereas, the fourth Wednesday in February is an appropriate day to observe Hypertrophic
Cardiomyopathy Awareness Day; now, therefore, be it
Resolved by the senate, the assembly concurring, That the Wisconsin Legislature designates
the fourth Wednesday in February of each year as “Hypertrophic Cardiomyopathy Awareness Day”
in Wisconsin in order to raise public awareness about hypertrophic cardiomyopathy; and, be it
further
Resolved, That the Wisconsin Legislature acknowledges the critical importance of
hypertrophic cardiomyopathy awareness to improve cardiovascular health in Wisconsin; and, be it
further
Resolved, That the Wisconsin Legislature supports raising awareness of the consequences of
undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for
hypertrophic cardiomyopathy as a serious public health issue; and, be it further
Resolved, That the Wisconsin Legislature respectfully requests the Governor to issue
annually a proclamation recognizing the fourth Wednesday in February in as “Hypertrophic 2023 Senate Joint Resolution 45
− 2−
Cardiomyopathy Awareness Day” in Wisconsin and calls upon the people in this state to observe the
day with appropriate programs and activities.
Representative Robin J. Vos
Speaker of the Assembly
Senator Chris Kapenga
President of the Senate
Date
Richard A. Champagne
Acting Senate Chief Clerk